AMARIN CORP PLC\UK — Investor Relations & Filings
Filings indexed
1,173
across all filing types
Latest filing
2026-05-14
Regulatory Filings
Country
US
United States of America
Listing
US
AMRN
Amarin Corporation plc is a pharmaceutical company focused on the development and commercialization of therapeutics to improve cardiovascular health. The company's primary mission is to address the persistent cardiovascular risk that remains for many patients despite standard therapies. Its lead product, Vascepa (icosapent ethyl), is a prescription-grade omega-3 fatty acid used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia and to reduce the risk of cardiovascular events in certain high-risk patient groups. Amarin is dedicated to creating a new paradigm in cardiovascular disease management to help prevent heart attacks and strokes for patients worldwide.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-14 | English | |
| 10-Q - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-04-29 | English | |
| 8-K - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-04-29 | English | |
| ARS - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-04-10 | English | |
| DEF 14A - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-04-10 | English | |
| PRE 14A | 2026-03-30 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46351928 | 8-K | 2026-05-14 | English | ||
| 38525507 | 10-Q - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-04-29 | English | ||
| 38525362 | 8-K - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-04-29 | English | ||
| 34033513 | ARS - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-04-10 | English | ||
| 34030022 | DEF 14A - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-04-10 | English | ||
| 46294752 | PRE 14A | 2026-03-30 | English | ||
| 33066048 | 8-K - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-03-27 | English | ||
| 32883539 | 10-K - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-03-02 | English | ||
| 32883534 | 8-K - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-02-25 | English | ||
| 25430200 | 4 Filing | 2026-02-03 | English | ||
| 25430173 | 4 Filing | 2026-02-03 | English | ||
| 25430042 | 4 Filing | 2026-02-03 | English | ||
| 25430032 | 4 Filing | 2026-02-03 | English | ||
| 25429960 | 4 Filing | 2026-02-03 | English | ||
| 25429904 | 8-K Filing | 2026-01-08 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Anhui Huangshan Capsule Co.,Ltd
Produces empty hard capsules, including gelatin and HPMC ve…
|
002817 | CN | Manufacturing |
|
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
Develops and manufactures pharmaceutical excipients for sol…
|
300452 | CN | Manufacturing |
|
Anika Therapeutics, Inc.
A global joint preservation company developing solutions fo…
|
ANIK | US | Manufacturing |
|
ANIMALCARE GROUP PLC
Develops and commercializes veterinary pharmaceutical produ…
|
ANCR | GB | Manufacturing |
|
ANI PHARMACEUTICALS INC
Develops, manufactures, and markets branded, generic, and O…
|
ANIP | US | Manufacturing |
|
ANLON HEALTHCARE LIMITED
Researches and manufactures APIs, intermediates, and finish…
|
AHCL | IN | Manufacturing |
|
Annexin Pharmaceuticals AB
Clinical-stage biotech developing a cell-protecting biologi…
|
ANNX | SE | Manufacturing |
|
Annexon, Inc.
Clinical-stage biopharma developing complement medicines by…
|
ANNX | US | Manufacturing |
|
Antengene Corporation Limited
Global biopharma developing and commercializing novel oncol…
|
6996 | KY | Manufacturing |
|
ANTEROGEN CO., LTD.
Develops and commercializes cell therapies and orphan drugs…
|
065660 | KR | Manufacturing |
AMARIN CORP PLC\UK via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33214/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33214 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33214 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33214 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33214}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AMARIN CORP PLC\UK (id: 33214)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.